22min chapter

Rethinking Wellness cover image

The Dangers of Diet Drugs: Behind the GLP-1 Weight-Loss Hype with Ragen Chastain

Rethinking Wellness

CHAPTER

Risks and Deceptive Practices in Weight Loss Drug Industry

The chapter explores the serious risks and potential side effects associated with weight loss drugs, revealing the lack of long-term safety data and the skewed risk-benefit analysis in the industry. It exposes the aggressive marketing tactics of pharmaceutical companies like Novo Nordisk and Eli Lilly, influencing media, funding campaigns, and lack of disclosure on financial ties with experts. Additionally, the unethical practices of a pharmaceutical company in promoting their weight-loss drug in the UK and the US are scrutinized, showcasing similarities with Purdue Pharma's notorious tactics.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode